CST3 and Nephropathy: This study demonstrates that ultra-high dose intravenous NAC does not prevent contrast-induced nephropathy in patients with impaired renal function undergoing emergency contrast CT-Scan, whatever the definition used for the condition and independently of the use of creatinine or cystatin C as markers of renal function.